On Monday, it was reported that Red Sox ace Chris Sale visited Dr. James Andrews for a second opinion on his ailing elbow and learned that, while he needed a PRP injection, he would not need Tommy John surgery. However, former MLB insider and former MLB general manager Jim Bowden believes that there is more to the story that the Red Sox are not sharing and is not 100% convinced that Tommy John surgery is completely off the table for Sale. (Jim Bowden on Twitter)
Now, Bowden is not a doctor and is just speculating here, but he does make some interesting points. He points out that while the Red Sox have said that an MRI showed inflammation in Sale's elbow, they have not said what caused that inflammation. Since the treatment they decided to go with was a PRP injection, that rules out bone spurs or loose bodies in the elbow and points more towards there being a slight tear to the UCL or an arthritic condition with the elbow. Look for an update on Sale's status in the coming weeks as we learn more about how he is responding to Monday's treatment.